| 5.63 -0.04 (-0.71%) | 05-22 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 7.36 | 1-year : | 8.01 |
| Resists | First : | 6.3 | Second : | 6.86 |
| Pivot price | 5.93  |
|||
| Supports | First : | 5.38 | Second : | 4.48 |
| MAs | MA(5) : | 5.76 |
MA(20) : | 6.08 |
| MA(100) : | 7.13 |
MA(250) : | 6.68 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 21.6 |
D(3) : | 26.1 |
| RSI | RSI(14): 34.2 |
|||
| 52-week | High : | 8.6 | Low : | 4.63 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LFST ] has closed above bottom band by 29.4%. Bollinger Bands are 72.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 5.68 - 5.72 | 5.72 - 5.75 |
| Low: | 5.5 - 5.56 | 5.56 - 5.6 |
| Close: | 5.55 - 5.63 | 5.63 - 5.68 |
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Wed, 14 May 2025
LifeStance Names Vaughn Paunovich as Chief Technology Officer - Quantisnow
Wed, 14 May 2025
Healthcare Tech Veteran from UnitedHealth and Amwell Joins LifeStance to Lead Digital Mental Health Innovation - Stock Titan
Tue, 13 May 2025
LifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2025 Earnings Call Transcript - Insider Monkey
Thu, 08 May 2025
Down -20.26% in 4 Weeks, Here's Why LifeStance Health (LFST) Looks Ripe for a Turnaround - Nasdaq
Thu, 08 May 2025
LifeStance Health Group First Quarter 2025 Earnings: EPS: US$0.002 (vs US$0.056 loss in 1Q 2024) - simplywall.st
Thu, 08 May 2025
LifeStance Health (LFST) Upgraded to Strong Buy: Here's Why - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 389 (M) |
| Shares Float | 134 (M) |
| Held by Insiders | 8.1 (%) |
| Held by Institutions | 93 (%) |
| Shares Short | 9,000 (K) |
| Shares Short P.Month | 8,570 (K) |
| EPS | -0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.75 |
| Profit Margin | -2.8 % |
| Operating Margin | 0.4 % |
| Return on Assets (ttm) | -0.4 % |
| Return on Equity (ttm) | -2.5 % |
| Qtrly Rev. Growth | 10.8 % |
| Gross Profit (p.s.) | 1.07 |
| Sales Per Share | 3.29 |
| EBITDA (p.s.) | 0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 126 (M) |
| Levered Free Cash Flow | 114 (M) |
| PE Ratio | -62.56 |
| PEG Ratio | 0 |
| Price to Book value | 1.5 |
| Price to Sales | 1.71 |
| Price to Cash Flow | 17.37 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|